1298032-47-9 Usage
Uses
Used in Pharmaceutical Applications:
1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole is used as a building block for the development of new pharmaceutical compounds due to its unique structure and functional groups. 1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole's potential to form various interactions with biological targets makes it a promising candidate for the creation of novel drugs.
Used in Materials Science:
In the field of materials science, 1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole is used as a component in the synthesis of advanced materials with specific properties. 1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole's structural features may contribute to the development of materials with tailored characteristics for various applications, such as electronics, coatings, or adhesives.
Used in Organic Synthesis:
1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole is utilized as an intermediate in organic synthesis, particularly for the preparation of complex organic molecules. 1-(2-Methoxy-2-methyl-propyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole's functional groups can be further modified or reacted to produce a wide range of target molecules, making it a versatile building block in the synthesis of various organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1298032-47-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,9,8,0,3 and 2 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1298032-47:
(9*1)+(8*2)+(7*9)+(6*8)+(5*0)+(4*3)+(3*2)+(2*4)+(1*7)=169
169 % 10 = 9
So 1298032-47-9 is a valid CAS Registry Number.
1298032-47-9Relevant academic research and scientific papers
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
-
, (2011/05/11)
The present invention relates to novel imidazo[1,2-b]pyridazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.
IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
-
, (2011/11/12)
The present invention relates to novel imidazo[1,2-b]pyridazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.
